BioNTech SE announced that Sean Marett, Chief Business and Commercial Officer, will retire as planned from the Management Board of BioNTech.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.3 USD | +11.11% | +10.95% | -3.07% |
May. 22 | Health Care Up as Vaccine Makers Gain - Health Care Roundup | DJ |
May. 22 | European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.07% | 24.69B | |
+9.99% | 115B | |
+12.01% | 106B | |
-1.16% | 21.97B | |
-5.06% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B | |
+13.63% | 7.76B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- BioNTech SE Announces Retirement of Sean Marett as Chief Business and Commercial Officer